Under current Part B, if an oncologist administers a $90,000 cancer drug, they earn a 6% commission – $5400. A generic drug, according to Emanuel, might cost only $3 per dose. The commission? – a mere 18 cents. Part B drug spending was $11 billion in 2009, implying a total commission of $620 million.